title: Do hepatitis C Virus genotypes influence liver dysfunction following rituximab-containing regimens in patients with diffuse large B cell lymphoma?
authors.affiliation: Department of Gastroenterology and Hepatology, Kurashiki Central Hospital, Japan. n.toshikuni@gmail.com
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Toshikuni
authors.forename: Takeshi
authors.initials: T
authors.lastname: Maeda
authors.forename: Yasunori
authors.initials: Y
authors.lastname: Ueda
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000410:Alanine Transaminase / Q000378:metabolism; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000150:complications / Q000473:pathology*; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000032:analysis; D012307:Risk Factors; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D012367:RNA, Viral; D000069283:Rituximab; D000410:Alanine Transaminase